http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9314518

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 716
issn 1551-7144
issueIdentifier 5
pageRange 710-716
publicationName Contemporary Clinical Trials
startingPage 710
bibliographicCitation Ruilope LM, Schaefer A. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study. Contemp Clin Trials. 2011 Sep;32(5):710–6. doi: 10.1016/j.cct.2011.04.011. PMID: 21586342.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c2ee224c3c9b47a8453e4d371562482
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61f4f71a923c258e43162d840301498c
date 201109
identifier https://doi.org/10.1016/j.cct.2011.04.011
https://pubmed.ncbi.nlm.nih.gov/21586342
isPartOf https://portal.issn.org/resource/ISSN/1551-7144
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32406
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study
discusses http://id.nlm.nih.gov/mesh/M0021253
http://id.nlm.nih.gov/mesh/M0129811
http://id.nlm.nih.gov/mesh/M0001207
http://id.nlm.nih.gov/mesh/M0003165
http://id.nlm.nih.gov/mesh/M0001456
http://id.nlm.nih.gov/mesh/M0026284
http://id.nlm.nih.gov/mesh/M0456879
http://id.nlm.nih.gov/mesh/M0403284
http://id.nlm.nih.gov/mesh/M0011048
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D017311Q000627
http://id.nlm.nih.gov/mesh/D012107
http://id.nlm.nih.gov/mesh/D006973Q000188
http://id.nlm.nih.gov/mesh/D000959Q000627
http://id.nlm.nih.gov/mesh/D013777Q000627
http://id.nlm.nih.gov/mesh/D020913Q000627
http://id.nlm.nih.gov/mesh/D007093Q000627
http://id.nlm.nih.gov/mesh/D000806Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D001011
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D002121Q000627
http://id.nlm.nih.gov/mesh/D016001
http://id.nlm.nih.gov/mesh/D012084Q000187
http://id.nlm.nih.gov/mesh/D012720
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D047228Q000627
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2315
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9ffa6b56d06ddd0c9bc50088955e425b
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11607546
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_00559ea764f3549e2a9c714ecd8af73f

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128203001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135860904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129815624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID81065529

Total number of triples: 63.